...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Message: Happy Thanksgiving all....

Just like the legendary Turducken, may BETonMACE find success in the three areas of cardio, renal and cognition. Someone else's creative mind will need to blend those three indications together into a single catchy delicious word.


New Message
Please login to post a reply